Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker

Background: Recent studies have identified that transglutaminases (TGMs) are involved in a widespread epigenetic modification in tumorigenesis. However, it remains unclear how transglutaminase 3 (TGM3) affects in pan-cancer. The present study aimed to explore the clinical and prognostic function of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenqing, Wu, Chenglong, Zhou, Kaili, Cao, Yu, Zhou, Wange, Zhang, Xue, Deng, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852731/
https://www.ncbi.nlm.nih.gov/pubmed/36685895
http://dx.doi.org/10.3389/fgene.2022.993438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852731/
https://www.ncbi.nlm.nih.gov/pubmed/36685895
http://dx.doi.org/10.3389/fgene.2022.993438

Ejemplares similares